Please login to the form below

Not currently logged in
Email:
Password:

Biogen appoints Jeff Capello as executive VP and CFO

He will lead the company's business and finance planning functions

Jeff CapelloBiotechnology company Biogen has appointed Jeff Capello as its executive vice president and chief financial officer, roles which will see him lead the company’s business planning, tax, treasury, internal audit, accounting and investor relations functions.

Reporting to chief executive officer of Biogen, Michel Vounatsos, Capello will also become a member of the executive committee and he will be based in its Massachusetts office in the US.

He said: “I am very excited to join Biogen, a company which is recognised as a pioneer and a leader in treating neurological diseases and I look forward to working with colleagues around the world in our mission to make a difference in the lives of patients.”

Capello brings 26 years of experience in finance to Biogen, with his most recent role being executive vice president and chief financial officer at Beacon Health Options.

His career experience has seen him serve in various positions for Monomy Advisors, Ortho Clinical Diagnostics, Boston Scientific Corporation and Perkin Elmer.

Vounatsos said: “We are fortunate to have Jeff join Biogen given the depth and breadth of his experience.

“He comes to Biogen at an exciting time as we execute our business strategy, pursue business development opportunities and build our pipeline.”

5th December 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics